Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| BIOStress | 2022 | Angel | $197K | Leeds |
| Sub-10 | 2022 | Seed | $924K | Gateshead |
| Freeline | 2022 | Post Ipo Equity | $26.1M | Stevenage |
| DIOSynVax | 2022 | Grant | $42.0M | Cambridge |
| Glaia | 2022 | Seed | $1.3M | Bristol |
| Aramune Technologies | 2022 | Seed | $1.1M | Belfast |
| Gylden Pharma | 2022 | Grant | $667K | Abingdon |
| 3AI | 2022 | Angel | $1.4M | London |
| Cufflink.io | 2022 | Non Equity Assistance | Undisclosed | Gaerwen |
| Cytochroma | 2021 | Seed | $1.3M | Edinburgh |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 901 | BIOStress | Angel | $197K | Leeds, United Kingdom |
| 902 | Sub-10 | Seed | $924K | Gateshead, United Kingdom |
| 903 | Freeline | Post Ipo Equity | $26.1M | Stevenage, United Kingdom |
| 904 | DIOSynVax | Grant | $42.0M | Cambridge, United Kingdom |
| 905 | Glaia | Seed | $1.3M | Bristol, United Kingdom |
| 906 | Aramune Technologies | Seed | $1.1M | Belfast, United Kingdom |
| 907 | Gylden Pharma | Grant | $667K | Abingdon, United Kingdom |
| 908 | 3AI | Angel | $1.4M | London, United Kingdom |
| 909 | Cufflink.io | Non Equity Assistance | Undisclosed | Gaerwen, United Kingdom |
| 910 | Cytochroma | Seed | $1.3M | Edinburgh, United Kingdom |
BIOStress is revolutionizing the understanding and management of workplace stress.
Sub-10 underpin both content and platform with learning methodology to design courses.
Freeline is a biotechnology company that develops transformative gene therapies for systemic debilitating diseases.
DIOSynVax is new technology that will significantly accelerate vaccine development and achieve dramatic improvements.
Glaia develops nanotechnology-based solutions for sustainable agriculture.
Aramune Technologies is developing natural, plant derived feed materials which can be mixed with standard animal feeds.
Pioneering a new approach to vaccine development and manufacturing using cutting-edge technologies to produce novel synthetic vaccines.
Empowering Investors with Big Data Insights
Cyber Security Software as a Service
Cytochroma manufacture genetically diverse stem cell to predict the safety and effect of drugs .
Sixfold Bioscience develops and researches on biotechnology advances for RNA therapies.
UrbanThings builds transit apps and smart ticketing platforms.
Version Control for Creative Teams
Armour Labs is an insurtech startup focused on providing employers and insurers with digital health solutions.
Sense Biodetection is a molecular diagnostics company .
Skyfarer makes the complex, simple, for advanced air mobility.
Developing personalised digital healthcare solutions to improve outcomes for patients and clinicians
We create stylish home automation, IoT devices that save energy and improve comfort. Globally active through Ovon Home and Ovon Technology.
Settld is a SaaS platform that automates cross-industry death notifications and offers end-to-end death administration management services.
Do Tomorrows Surgery Today.
End-to-end testing platform mobile apps.
G2O is a UK-based graphene innovation and application company whose patented technology is aimed at tackling the world’s water shortage.
Oxford Heartbeat makes cardiovascular surgery more accurate and safe.
Orbit Discovery is a peptide display company identifying potential peptide drugs for a range of chronic diseases.
3D Printing technology company dedicated to unlocking 3D printing as a viable alternative to traditional manufacturing.
Innovate UK has invested in 993 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Innovate UK's top investment sectors include Biotechnology, Health Care, Software, Information Technology, Therapeutics. The firm invests across 48 different industry categories.
Among tracked funding rounds, DIOSynVax received $42.0M in a Grant round. Innovate UK's total known invested capital is $3.3B.
Innovate UK's average investment size is $3.9M across its portfolio of 993 companies.
Recent Innovate UK portfolio additions include BIOStress, Sub-10, Freeline, DIOSynVax, Glaia. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors